PLURY is redefining the future of skin health through prejuvenation — the science of prevention before correction.
Proudly developed and manufactured in Korea, PLURY delivers advanced skincare and clinical-grade cell therapy solutions backed by exclusive global rights to FECS™ (Functionally Enhanced Cell Spheroid) technology.
Our portfolio includes:
• s4S SOLUTION — the world’s first clinical prejuvenation product for skin longevity
• CFC-FECS-DF — a regenerative skincare ingredient powered by cell secretions
• Cell therapy joint ventures — customizable anti-aging treatments using autologous fibroblast spheroids
With roots in regenerative medicine and a vision for global wellness, PLURY serves clinics, professionals, and consumers seeking real science behind youthful, resilient skin.
We don’t reverse time — we strengthen skin to resist it.
Company Details
- Employees
- 4
- Address
- Seongsu-Ee Ro 26-Gil, 28, Seoul,korea, Republic Of
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://linktr.ee/prejuvenation
- Keywords
- prejuvenation, regenerative skincare, cell therapy, preventive aesthetics, cosmeceuticals, professional skincare, skin longevity, aesthetic medicine, biotech skincare, anti-aging, advanced skincare solutions, s4s solution, korean skincare innovation, clinical aesthetic partnerships, fibroblast, aesthetics, korean skincare, fibroblast technology, biotech skincare.
- HQ
- Seoul
Plury Questions
Plury's website is https://linktr.ee/prejuvenation
Plury's LinkedIn profile is https://kr.linkedin.com/company/plury
Plury has
4 employees.
View email and phone details for 4
employees at Plury.
Plury's industry is
Hospitals and Health Care
Plury's top competitors are
Av Marcom,
さつまいもカンパニー(株) (Sweet Potato Company Inc,
Astr Inc.,
Cibi Genuini - Più Che Bio,
Biocenter France,
Bio-Tech Distributions Ltd.,
Oh K Fresh,
Takemoneys,
Damogo,
Korea Kolmar Holdings Co Ltd.
Plury's categories are Hospitals and Health Care
